Israel biotech startup NextFerm Technologies and Mascoma agreed to work together to develop ethanol from grain starch and fiber. "Our strategy is quite comprehensive and is specifically focused on developing novel or 'better than' active ingredients via a heavy investment in science and technology to provide a lasting edge for our products," says Elzaphan Hotam, vice president of global marketing at NextFerm.
A round of financing involving Ping An Global Voyager Fund and other investors has pulled in more than $70 million for Haifa, Israel-based diagnostics firm MeMed.
The company will use the funds to complete development and clearance and upscale manufacturing for its point-of-care protein-measurement platform MeMed Key; expand market adoption of MeMed BV, an immune system-based test for viral and bacterial infection differentiation; and increase its pipeline of innovative tests that use immune-based measurements and machine learning technology.
Representatives from AdvaMed India and other medical technology trade groups came together recently to discuss ways to contribute to India's Ayushman Bharat program, which aims to provide free health care access to the poorest 40% of the country's population. "Medtech industry can actively partner with the government and providers to transform health care in India by structuring effective patient care pathways along with outcome-based models," said AdvaMed India Chair Madan Krishnan.
A majority stake in Japanese joint venture ACTmed was acquired by Canon Medical Systems. The acquisition transfers to ACTmed ACT Genomics' clinical next-generation sequencing technology, including the ACTOnco+ assay for determining mutational status of solid tumors and guiding treatment selection.
New technological innovation and better surgical techniques are among the factors driving growth of the joint-replacement implants market, including in younger patients. The market is expected to hit $20 billion by 2022, with shoulder arthroplasty being the fastest-growing procedure.
Boston Scientific's Eluvia drug-eluting vascular stent system was found to be more effective for symptomatic peripheral artery disease than Cook Medical's Zilver PTX drug-eluting peripheral stent in a head-to-head study presented at the Cardiovascular Research Foundation's annual scientific symposium and the Cardiovascular and Interventional Radiological Society of Europe Congress.
There were no major adverse events in more than 95% of patients receiving Eluvia at 12 months, compared with 91% of patients receiving Zilver PTX.
Boston Scientific has released its LithoVue Empower Retrieval Deployment Device with immediate availability in the US and Europe. The device is a companion to the company's LithoVue Single-Use Digital Flexible Ureteroscope and compatible nitinol retrieval basket to enable simultaneous operation of a ureteroscope and basket during flexible ureteroscopy to retrieve kidney stones.
Merck announced that a positive opinion was given by the European Medicines Agency's Committee for Medicinal Products for Human Use for the approval of its marketing authorization for two of its HIV-1 medications: Delstrigo, a combination tablet containing doravirine, lamivudine and tenofovir disoproxil fumarate, and Pifeltro, or doravirine.
Cargill Meat Solutions issued a recall for 66.3 tons of ground beef produced at the company's Fort Morgan, Colo., facility after a four-state E. coli O26 outbreak sickened 18 people, including one person who died and six who were hospitalized. The recalled products were fine grind beef products, which bear the establishment number EST. 86R and were distributed to retail locations across the US.